SAO PAULO (Reuters) -Brazilian hospital chain Rede D'Or said on Wednesday it had signed definitive documents to sell its stake in GSH, a firm which operates in hemotherapy and cellular therapy, to CVC ...

S$10.2m (loss narrowed by 8.6% from FY 2023). S$0.005 loss per share (improved from S$0.006 loss in FY 2023). AI is about to change healthcare. These 20 stocks are working on everything from early ...

Glutathione (GSH) is the most abundant non-protein thiol in eukaryotic cells. Together with its oxidized partner (GSSG), GSH maintains cellular redox homeostasis and regulates protein functions ...